RT Book, Section A1 Gammal, Roseann S. A1 Caudle, Kelly E. A2 Lam, Jerika T. A2 Gutierrez, Mary A. A2 Shah, Samit SR Print(0) ID 1179509729 T1 Pharmacogenomics Resources T2 Pharmacogenomics: A Primer for Clinicians YR 2021 FD 2021 PB McGraw Hill PP New York, NY SN 9781260457100 LK accesspharmacy.mhmedical.com/content.aspx?aid=1179509729 RD 2024/03/29 AB LEARNING OBJECTIVESDescribe the benefits and limitations of pharmacogenomic information found in the U.S. Food and Drug Administration labeling.Differentiate between pharmacogenomics guidelines from the Clinical Pharmacogenetics Implementation Consortium, the Dutch Pharmacogenetics Working Group, and the Canadian Pharmacogenomics Network for Drug Safety Consortium.Explain the type of information found in online pharmacogenomics databases, including the Pharmacogenomics Knowledgebase, PharmVar, ClinGen, ClinVar, the Genetic Testing Registry, and the Genetics/Genomics Competency Center.Identify key resources that support the clinical implementation of pharmacogenomics, including the integration of pharmacogenomic test results into electronic health records with clinical decision support.Use an appropriate resource to find the relevant information when presented with a clinical pharmacogenomics case.